Is venture capital bad for life sciences? 3 reasons why (and what should replace it)
Impact financing, venture philanthropy and a new breed of investors, says MIT's Andrew Lo.
Impact financing, venture philanthropy and a new breed of investors, says MIT's Andrew Lo.